Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: david james who wrote (1126)	5/20/2000 3:44:00 AM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 52153

Given that the feeling is that antibodies are in vogue for ASCO, how come no one is mentioning IMGN? It has a loyal following on it's own thread, but there isn't much real information there. I own some of this one and I am really wondering about the valuation. I find the technology rather intriguing and I really cannot understand why their recent deals didn't produce any significant movement in the stock. Oh well, we'll see after ASCO. Disclaimer: I'm a bit long on this one. I'm just curious as to what others think about it and there's not much meat on the IMGN thread. Thanks, Torben